In patients with chronic hepatitis C, the values of other fibrosis markers were hyaluronic acid (HA) at a median of 113.5 ng/mL (IQR, 7.9-826.9 ng/mL); transforming growth factor‐β1 (TGF-β1) at a median of 8.0 ng/mL (IQR, 2.12–31.5 ng/mL); APRI index at a median of 0.69 (IQR, 0.20–12.1); FIB-4 score at a median of 3.43 (IQR, 0.28–30.6); AST/ALT ratio at a median of 0.91 (IQR, 0.45–2.70); and GPR ratio at a median of 0.31 (IQR, 0.40-6.62) (Table 1). Here, GPT is linked to chronic hepatitis C virus infection.